Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

Saxenda (liraglutide) and Wegovy (semaglutide) are prescription drugs used for weight loss and weight management. Both drugs come as a liquid solution injected under your skin. Saxenda is available in ...

Saxenda is a brand name for the weight loss injectable medicine, Liraglutide. It was approved by the FDA for weight loss nearly a decade ago. Saxenda has been labeled ‘the skinny jab’ and the ‘miracle ...

Credit: FDA. Increased demand for the drug has resulted in supply interruptions. Saxenda (liraglutide) may be in short supply through the end of 2023, according to the Food and Drug Administration’s ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

After Novo Nordisk’s popular obesity medicine Wegovy went into short supply, people turned to the company’s first-generation weight-loss drug, Saxenda, for treatment. Now, the company is struggling to ...

World Health Organization advisors will meet next month to decide whether liraglutide will be added to the organization’s updated Essential Medicines List, making the drug available in all hospital ...

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major U.S ...

Share on Pinterest Experts say people should expect to be on weight loss medications for a long period of time. NurPhoto/Getty Images Researchers report that more than half of people on weight loss ...

Regulators in Europe have launched a review after three people in Iceland experienced thoughts of suicide or self-harm after taking popular diabetes and weight loss drugs Ozempic and Saxenda. The ...

Trish Webster died of acute gastrointestinal illness after several months of taking Ozempic and Saxenda Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard ...